ASCO 2022 Conference Coverage


 

ASCO 2022 CeNtuRIOn: Rucaparib With Nivo & Ipi in Relapsed Ovarian Cancer - Results of the Initial Safety Cohort

152 views
June 15, 2022
0 Comments
Login to view comments. Click here to Login